Increased Presentation of Diabetic Ketoacidosis and Changes in Age and Month of Type 1 Diabetes at Onset during the COVID-19 Pandemic in Spain

por Leiva-Gea, Isabel, Antúnez Fernández, Cristina, Cardona-Hernandez, Roque, Ferrer Lozano, Marta, Bahíllo-Curieses, Pilar, Arroyo-Díez, Javier, Clemente León, María, Martín-Frías, Maria, Conde Barreiro, Santiago, Mingorance Delgado, Andrés, Pérez Sánchez, Jacobo
Publicado 2022

Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2

por Nowak, Christoph, Lind, Marcus, Sumnik, Zdenek, Pelikanova, Terezie, Nattero-Chavez, Lía, Lundberg, Elena, Rica, Itxaso, Martínez-Brocca, Maria A, Ruiz de Adana, MariSol, Wahlberg, Jeanette, Hanas, Ragnar, Hernandez, Cristina, Clemente-León, Maria, Gómez-Gila, Ana, Ferrer Lozano, Marta, Sas, Theo, Pruhova, Stepanka, Dietrich, Fabricia, Puente-Marin, Sara, Hannelius, Ulf, Casas, Rosaura, Ludvigsson, Johnny
Publicado 2022

Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial

por Ludvigsson, Johnny, Sumnik, Zdenek, Pelikanova, Terezie, Nattero Chavez, Lia, Lundberg, Elena, Rica, Itxaso, Martínez-Brocca, Maria A., Ruiz de Adana, Marisol, Wahlberg, Jeanette, Katsarou, Anastasia, Hanas, Ragnar, Hernandez, Cristina, Clemente León, Maria, Gómez-Gila, Ana, Lind, Marcus, Lozano, Marta Ferrer, Sas, Theo, Samuelsson, Ulf, Pruhova, Stepanka, Dietrich, Fabricia, Puente Marin, Sara, Nordlund, Anders, Hannelius, Ulf, Casas, Rosaura
Publicado 2021